Beta-blockers in pulmonary arterial hypertension: Time for a second thought?

Authors :: R. Badagliacca
V. Mercurio
E. Romeo
M. Correale
D. Masarone
S. Papa
C.G. Tocchetti
P. Agostoni
Badagliacca, R.
Mercurio, V.
Romeo, E.
Correale, M.
Masarone, D.
Papa, S.
Tocchetti, C. G.
Agostoni, P.
Publication Year :: 2022
Abstract: Pulmonary arterial hypertension (PAH) is a heart failure syndrome characterized by right ventricular (RV) to pulmonary circulation uncoupling, counteracted by the sympathetic nervous system activation leading to β